Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Nitrosomonas europaea S-adenosylmethionine:tRNA ribosyltransferase-isomerase (queA) CSB-YP769261NHH
CSB-EP769261NHH
CSB-BP769261NHH
CSB-MP769261NHH
CSB-EP769261NHH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas europaea 50S ribosomal protein L31 (rpmE) CSB-YP769262NHH
CSB-EP769262NHH
CSB-BP769262NHH
CSB-MP769262NHH
CSB-EP769262NHH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas europaea UDP-N-acetylmuramate--L-alanine ligase (murC) CSB-YP769263NHH
CSB-EP769263NHH
CSB-BP769263NHH
CSB-MP769263NHH
CSB-EP769263NHH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas europaea UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase (murE), partial CSB-YP769264NHH
CSB-EP769264NHH
CSB-BP769264NHH
CSB-MP769264NHH
CSB-EP769264NHH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas europaea 50S ribosomal protein L20 (rplT) CSB-YP769265NHH
CSB-EP769265NHH
CSB-BP769265NHH
CSB-MP769265NHH
CSB-EP769265NHH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas europaea Elongation factor P (efp) CSB-YP769266NHH
CSB-EP769266NHH
CSB-BP769266NHH
CSB-MP769266NHH
CSB-EP769266NHH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas europaea Phosphoribosylaminoimidazole-succinocarboxamide synthase (purC) CSB-YP769267NHH
CSB-EP769267NHH
CSB-BP769267NHH
CSB-MP769267NHH
CSB-EP769267NHH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas europaea Cytochrome c biogenesis ATP-binding export protein CcmA (ccmA) CSB-YP769268NHH
CSB-EP769268NHH
CSB-BP769268NHH
CSB-MP769268NHH
CSB-EP769268NHH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas europaea N- (5'-phosphoribosyl)anthranilate isomerase (trpF) CSB-YP769269NHH
CSB-EP769269NHH
CSB-BP769269NHH
CSB-MP769269NHH
CSB-EP769269NHH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas europaea Adenosylhomocysteinase (ahcY) CSB-YP769270NHH
CSB-EP769270NHH
CSB-BP769270NHH
CSB-MP769270NHH
CSB-EP769270NHH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas europaea Phosphoribosyl-AMP cyclohydrolase (hisI) CSB-YP769271NHH
CSB-EP769271NHH
CSB-BP769271NHH
CSB-MP769271NHH
CSB-EP769271NHH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas europaea Bis (5'-nucleosyl)-tetraphosphatase, symmetrical (apaH) CSB-YP769272NHH
CSB-EP769272NHH
CSB-BP769272NHH
CSB-MP769272NHH
CSB-EP769272NHH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas europaea UPF0289 protein NE0599 (NE0599) CSB-YP769273NHH
CSB-EP769273NHH
CSB-BP769273NHH
CSB-MP769273NHH
CSB-EP769273NHH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas europaea Fructose-1,6-bisphosphatase class 1 (fbp) CSB-YP769274NHH
CSB-EP769274NHH
CSB-BP769274NHH
CSB-MP769274NHH
CSB-EP769274NHH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas europaea Heme A synthase (ctaA), partial CSB-YP769275NHH
CSB-EP769275NHH
CSB-BP769275NHH
CSB-MP769275NHH
CSB-EP769275NHH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas europaea 30S ribosomal protein S8 (rpsH) CSB-YP769276NHH
CSB-EP769276NHH
CSB-BP769276NHH
CSB-MP769276NHH
CSB-EP769276NHH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas europaea 50S ribosomal protein L16 (rplP) CSB-YP769277NHH
CSB-EP769277NHH
CSB-BP769277NHH
CSB-MP769277NHH
CSB-EP769277NHH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas europaea 30S ribosomal protein S10 (rpsJ) CSB-YP769278NHH
CSB-EP769278NHH
CSB-BP769278NHH
CSB-MP769278NHH
CSB-EP769278NHH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas europaea Bifunctional protein FolD (folD) CSB-YP769279NHH
CSB-EP769279NHH
CSB-BP769279NHH
CSB-MP769279NHH
CSB-EP769279NHH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas europaea Probable Fe (2+)-trafficking protein (NE0322) CSB-YP769280NHH
CSB-EP769280NHH
CSB-BP769280NHH
CSB-MP769280NHH
CSB-EP769280NHH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶(hù)提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>